urapidil has been researched along with Aging in 5 studies
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urapidil, an antihypertensive agent with dual action (alpha 1-adrenergic antagonist and 5HT1A agonist) is well established in the treatment of arterial hypertension." | 4.79 | Review of studies with urapidil in elderly hypertensives. ( Hansson, L; Petitet, A, 1995) |
| "Urapidil is a selective alpha 1-adrenoceptor antagonist with central antihypertensive action which is increasingly used in the treatment of hypertension." | 4.77 | Clinical pharmacokinetics of urapidil. ( Haerlin, R; Kirsten, R; Nelson, K; Steinijans, VW; Zech, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leposavić, G | 1 |
| Pešić, V | 1 |
| Stojić-Vukanić, Z | 1 |
| Radojević, K | 1 |
| Arsenović-Ranin, N | 1 |
| Kosec, D | 1 |
| Perišić, M | 1 |
| Pilipović, I | 1 |
| Hansson, L | 1 |
| Petitet, A | 1 |
| Buñag, RD | 1 |
| Thomas, CV | 1 |
| Mellick, JR | 1 |
| Kirsten, R | 1 |
| Nelson, K | 1 |
| Steinijans, VW | 1 |
| Zech, K | 1 |
| Haerlin, R | 1 |
2 reviews available for urapidil and Aging
| Article | Year |
|---|---|
Review of studies with urapidil in elderly hypertensives.
Topics: Aging; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Piperazines | 1995 |
Clinical pharmacokinetics of urapidil.
Topics: Adult; Aged; Aged, 80 and over; Aging; Digoxin; Drug Interactions; Half-Life; Humans; Hypertension; | 1988 |
3 other studies available for urapidil and Aging
| Article | Year |
|---|---|
Age-associated plasticity of α1-adrenoceptor-mediated tuning of T-cell development.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aging; Animals; Apoptosis; CD4-Positive T-Lymphocytes; CD8- | 2010 |
Adaptation of antihypertensive drug treatment with increasing age: from the young to the elderly. Focus on urapidil.
Topics: Adult; Aged; Aging; Antihypertensive Agents; Humans; Hypertension; Middle Aged; Piperazines | 1995 |
Ketanserin versus urapidil: age-related cardiovascular effects in conscious rats.
Topics: Aging; Angiotensins; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradycardia; Keta | 2002 |